Fares Ghanem

ORCID: 0000-0001-9592-6452
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Cardiac Structural Anomalies and Repair
  • Cardiac Arrest and Resuscitation
  • Mechanical Circulatory Support Devices
  • Aortic Disease and Treatment Approaches
  • Infective Endocarditis Diagnosis and Management
  • Cardiomyopathy and Myosin Studies
  • Global Public Health Policies and Epidemiology
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Health and Risk Factors
  • Cardiovascular Issues in Pregnancy
  • Cardiovascular Function and Risk Factors
  • COVID-19 and healthcare impacts
  • Cardiac, Anesthesia and Surgical Outcomes
  • Coronary Interventions and Diagnostics
  • Healthcare Systems and Public Health
  • Pharmaceutical Economics and Policy
  • Cardiac Imaging and Diagnostics
  • Venous Thromboembolism Diagnosis and Management
  • Congenital Heart Disease Studies
  • Acute Ischemic Stroke Management
  • Cardiac Health and Mental Health
  • Clinical practice guidelines implementation
  • Traumatic Ocular and Foreign Body Injuries
  • Cerebrovascular and Carotid Artery Diseases

Southern Illinois University School of Medicine
2023-2025

East Tennessee State University
2022-2024

Southern Illinois University System
2024

Michigan United
2024

University of Minnesota
2024

Oregon Health & Science University
2024

University of Jordan
2017

Background Prior national data showed a substantial in-hospital mortality in septal myectomy (SM) with an inverse volume-outcomes relationship. This study sought to assess the contemporary outcomes of reduction therapy and volume-outcome relationship obstructive hypertrophic cardiomyopathy. Methods Results All admissions between 2010 2019 United States were analyzed using National Readmission Databases. Hospitals stratified into tertiles low-, medium-, high-volume based on annualized...

10.1161/jaha.122.028693 article EN cc-by-nc-nd Journal of the American Heart Association 2023-05-15

Thrombotic thrombocytopenic purpura (TTP) is a rare microangiopathic hemolytic anemia caused by deficiency in the von Willebrand factor-cleaving protease ADAMTS13, resulting formation of microthrombi. TTP associated with severe cardiovascular complications, such as myocardial infarction, congestive heart failure, arrhythmias, and cardiogenic shock, which can lead to poor prognosis. Although plasmapheresis cornerstone treatment, it complicates interpretation cardiac biomarkers due rapid...

10.1177/00185787251328593 article EN Hospital Pharmacy 2025-03-20

10.1016/j.jscai.2024.101410 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2024-05-01

With medical development various cardiovascular disease have experienced drastic changes in management and incidence ST-segment elevation myocardial infarction (STEMI) is no exception. We aimed to analyze demographic trends STEMI hospitalizations the United States using nationwide inpatient data from 2004 2020. calculated annual hospitalization per population rates assessed trend through regression analysis. A total of 3,426,898 eligible patients were analyzed. The overall steadily decreased...

10.1016/j.jscai.2024.101440 article EN cc-by-nc-nd Journal of the Society for Cardiovascular Angiography & Interventions 2024-05-01
Coming Soon ...